Trial Profile

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Status: Recruiting

Phase of Trial: Phase 0

Latest Information Update: 28 Aug 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PBA 0111 (Primary)
Indications Alveolar soft part sarcoma; Fibrosarcoma; Haemangiosarcoma; Head and neck cancer; Malignant fibrous histiocytoma; Soft tissue sarcoma; Solid tumours; Squamous cell cancer; Synovial sarcoma; Triple negative breast cancer
Focus Pharmacodynamics
Sponsors Pure Biologics

Most Recent Events

11 Aug 2025 Status changed from not yet recruiting to recruiting.
28 Nov 2024 New trial record
21 Nov 2024 According to a Pure Biologics media release, this study is expected to conclude in H1 2024. Prior to that, the Company expects partial results as the study progresses.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com